Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1790

-0.0046

-0.39%

GBP/USD

1.3434

0.0023

0.17%

USD/JPY

112.26

-0.4720

-0.42%

USD/CHF

0.9877

0.0022

0.23%

EUR/GBP

0.8777

-0.0049

-0.56%

USD/CAD

1.2751

-0.0066

-0.51%

NZD/USD

0.6989

-0.0029

-0.42%

EUR/JPY

132.36

-1.0720

-0.80%

EUR/CHF

1.1645

-0.0019

-0.16%

Skystar Bio-Pharmaceutical Company

NASDAQ: SKBIHealthcare / Drug Manufacturers - Major / China
0.0100.00Vol 55 0611Y Perf -92.59%
Dec 14th, 2017 13:20
BID0.00 ASK0.00
Open0.01 Previous Close0.01
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)0 
Earnings Rating
Price Range Ratio 52wk %
5.30 
Earnings Date

Today's Price Range

0.010.01

52wk Range

0.000.187

5 Year PE Ratio Range

0.7016.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
0.00%
3 Months
0.00%
6 Months
-83.33%
1 Year
-92.59%
3 Years
-99.78%
5 Years
-99.38%
Last Quotes
Name / TickerPriceChg.Chg.%
SKBI0.010.00000.00
AAPL172.310.04000.02
GOOG1 048.067.45000.72
MSFT84.69-0.6600-0.77
XOM83.07-0.0500-0.06
WFC59.35-0.0500-0.08
JNJ141.74-1.1500-0.80
FB178.470.17000.10
GE17.65-0.1100-0.62
JPM104.77-0.7400-0.70
...

TickerPriceChg.%52 Week High
FOXA35.057.0235.04
FOX34.306.0634.34
MAT16.375.0031.60
DIS111.223.35116.10
TIF99.113.13100.80
DAL55.212.9555.75
STZ223.862.42227.20
WMB29.722.2732.69
CBS58.221.8470.10
EQIX459.271.77495.35
EXPE120.541.68161.00
MCK157.801.67169.29
COP52.511.6154.22
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.10
Current Ratio 2.50
Long Term Debt to Total Capital -
Total Debt to Equity 0.16
Interest Coverage 27.30
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin46.20
EBIT Margin28.50
EBITDA Margin32.30
Pre-tax Profit Margin29.30
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 0.00
PB Ratio 0.02
PS Ratios -
Price to Cash Flow 0.10
Price to Free Cash Flow -
Cash Flow Per Share 2.17
Price to Tangible Book0.00
Book Value per Share14.09
Enterprise Value (in ths.)5 924
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)14.10
ROE last 12 Months 9.61
Return on Assets (5Y Avg) 6.93
ROA last 12 Months 7.16
Return on Capital (5Y Avg) 8.96
ROC last 12 Months 8.42
Return on invested Capital Q 3.64
Return on invested Capital Y9.50
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2014-0.57-
Q02 2014-0.36-
Q01 2014-0.13-
Q04 2013-0.29-
Q03 2013-0.49-
Q02 2013-0.49-
Q01 2013-0.09-
Q04 2012--0.02-
Earnings Per EndEstimateRevision %Trend
9/2011 QR---
12/2011 QR---
12/2011 FY---
12/2012 FY---
Next Report Date1st Jan 2016
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume55 061
Shares Outstanding (in ths.)8 700
Trades Count0
Dollar Volume0
Avg. Volume8 629
Avg. Weekly Volume4 880
Avg. Monthly Volume9 365
Avg. Quarterly Volume10 300

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x